Clin Exp Otorhinolaryngol.  2024 Aug;17(3):241-252. 10.21053/ceo.2023.00038.

Surgical and Regenerative Treatment Options for Empty Nose Syndrome: A Systematic Review

• Kim DH
• Basurrah MA
• Kim SW
• Kim SW

• KMID: 2558841
• DOI: http://doi.org/10.21053/ceo.2023.00038

Abstract

Objectives
. Patients with empty nose syndrome typically experience paradoxical nasal congestion, nasal dryness, epistaxis, and suffocation. Conservative management is generally preferred for empty nose syndrome. However, some patients continue to experience persistent symptoms. When symptoms do not resolve, surgical options are considered. Therefore, we reviewed the surgical and regenerative treatment options for empty nose syndrome.
Methods
. PubMed, Embase, Scopus, Cochrane Register of Controlled Trials, and Google Scholar were searched from the earliest date provided in the database until December 2022. This review included studies that assessed treatment outcomes using patient symptom scores, including the Sino-Nasal Outcome Test (SNOT-20, -22, and -25) and the Empty Nose Syndrome 6-Item Questionnaire, supplemented by various clinical examinations.
Results
. Twenty-eight studies were analyzed. Various materials were utilized, including submucosal injectable materials, allografts/xenografts/cadaveric implants, autologous implants, and synthetic implants. The polyethylene implant was the most commonly used (23.3%), followed by autologous, homologous, or cadaveric costal cartilage (20%). The anterior-inferior lateral nasal wall was the most frequent site of administration. Most studies indicated that surgical intervention led to significant improvements in clinical outcomes, as evidenced by endoscopic exams, acoustic rhinometry, and computed tomography scans, along with patient-reported enhancements in nasal symptoms, psychological well-being, and overall health-related quality of life. However, several studies found no improvement in certain psychological-related questionnaires or saccharin transit times. The average follow-up duration was 12.0 months (range, 2.0–27.6 months). Only two studies reported postoperative adverse effects.
Conclusion
. Several surgical options and recent tissue regeneration techniques have demonstrated efficacy in treating empty nose syndrome. However, more detailed investigations involving a larger number of participants and a randomized control study are necessary to establish a standardized treatment protocol for patients with empty nose syndrome.

Keyword

Atrophic Rhinitis; Therapeutics; Operative Surgical Procedures; Sino-Nasal Outcome Test; Review

Figure

• 

  Fig. 1. Study selection process.

Reference

1. Coste A, Dessi P, Serrano E. Empty nose syndrome. Eur Ann Otorhinolaryngol Head Neck Dis. 2012; Apr. 129(2):93–7.

2. Hong HR, Jang YJ. Correlation between remnant inferior turbinate volume and symptom severity of empty nose syndrome. Laryngoscope. 2016; Jun. 126(6):1290–5.

3. Talmadge J, Nayak JV, Yao W, Citardi MJ. Management of postsurgical empty nose syndrome. Facial Plast Surg Clin North Am. 2019; Nov. 27(4):465–75.

4. Moore EJ, Kern EB. Atrophic rhinitis: a review of 242 cases. Am J Rhinol. 2001; Nov-Dec. 15(6):355–61.

5. Chhabra N, Houser SM. The diagnosis and management of empty nose syndrome. Otolaryngol Clin North Am. 2009; Apr. 42(2):311–30.

6. Houser SM. Empty nose syndrome associated with middle turbinate resection. Otolaryngol Head Neck Surg. 2006; Dec. 135(6):972–3.

7. Scheithauer MO. Surgery of the turbinates and “empty nose” syndrome. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2010; 9:Doc03.

8. Gill AS, Said M, Tollefson TT, Steele TO. Update on empty nose syndrome: disease mechanisms, diagnostic tools, and treatment strategies. Curr Opin Otolaryngol Head Neck Surg. 2019; Aug. 27(4):237–42.

9. Li C, Farag AA, Maza G, McGhee S, Ciccone MA, Deshpande B, et al. Investigation of the abnormal nasal aerodynamics and trigeminal functions among empty nose syndrome patients. Int Forum Allergy Rhinol. 2018; Mar. 8(3):444–52.

10. Payne SC. Empty nose syndrome: what are we really talking about. Otolaryngol Clin North Am. 2009; Apr. 42(2):331–7.

11. Kim DH, Kim SW, Basurrah MA, Hwang SH. Clinical and laboratory features of various criteria of eosinophilic chronic rhinosinusitis: a systematic review and meta-analysis. Clin Exp Otorhinolaryngol. 2022; Aug. 15(3):230–46.

12. Hwang SH, Kim SW, Basurrah MA, Kim DH. Efficacy of steroid-impregnated spacers after endoscopic sinus surgery in chronic rhinosinusitis: a systematic review and meta-analysis. Clin Exp Otorhinolaryngol. 2023; May. 16(2):148–58.

13. Kim DH, Kim SW, Stybayeva G, Lim SY, Hwang SH. Predictive value of olfactory and taste symptoms in the diagnosis of COVID-19: a systematic review and meta-analysis. Clin Exp Otorhinolaryngol. 2021; Aug. 14(3):312–20.

14. Kim DH, Lee J, Kim SW, Hwang SH. The efficacy of hypotensive agents on intraoperative bleeding and recovery following general anesthesia for nasal surgery: a network meta-analysis. Clin Exp Otorhinolaryngol. 2021; May. 14(2):200–9.

15. Rice DH. Rebuilding the inferior turbinate with hydroxyapatite cement. Ear Nose Throat J. 2000; Apr. 79(4):276–7.

16. Houser SM. Surgical treatment for empty nose syndrome. Arch Otolaryngol Head Neck Surg. 2007; Sep. 133(9):858–63.

17. Jaswal A, Jana AK, Sikder B, Nandi TK, Sadhukhan SK, Das A. Novel treatment of atrophic rhinitis: early results. Eur Arch Otorhinolaryngol. 2008; Oct. 265(10):1211–7.

18. Jang YJ, Kim JH, Song HY. Empty nose syndrome: radiologic findings and treatment outcomes of endonasal microplasty using cartilage implants. Laryngoscope. 2011; Jun. 121(6):1308–12.

19. Modrzynski M. Hyaluronic acid gel in the treatment of empty nose syndrome. Am J Rhinol Allergy. 2011; Mar-Apr. 25(2):103–6.

20. Salaheldin AH, Hussein A. Effect of platelet-rich plasma on nasal mucociliary clearance after submucous diathermy of inferior turbinate. Egypt J Ear Nose Throat Allied Sci. 2012; Jul. 13(2):71–5.

21. Jiang C, Shi R, Sun Y. Study of inferior turbinate reconstruction with Medpor for the treatment of empty nose syndrome. Laryngoscope. 2013; May. 123(5):1106–11.

22. Jung JH, Baguindali MA, Park JT, Jang YJ. Costal cartilage is a superior implant material than conchal cartilage in the treatment of empty nose syndrome. Otolaryngol Head Neck Surg. 2013; Sep. 149(3):500–5.

23. Saafan ME. Acellular dermal (AlloDerm) grafts versus silastic sheets implants for management of empty nose syndrome. Eur Arch Otorhinolaryngol. 2013; Feb. 270(2):527–33.

24. Friji MT, Gopalakrishnan S, Verma SK, Parida PK, Mohapatra DP. New regenerative approach to atrophic rhinitis using autologous lipoaspirate transfer and platelet-rich plasma in five patients: our experience. Clin Otolaryngol. 2014; Oct. 39(5):289–92.

25. Jiang C, Wong F, Chen K, Shi R. Assessment of surgical results in patients with empty nose syndrome using the 25-item Sino-Nasal Outcome Test Evaluation. JAMA Otolaryngol Head Neck Surg. 2014; May. 140(5):453–8.

26. Tam YY, Lee TJ, Wu CC, Chang PH, Chen YW, Fu CH, et al. Clinical analysis of submucosal Medpor implantation for empty nose syndrome. Rhinology. 2014; Mar. 52(1):35–40.

27. Bastier PL, Fierens S, Champel S, Ribadeau-Dumas A, de Gabory L. ß-Tricalcium phosphate implants in the surgical treatment of empty nose syndrome. Otolaryngol Head Neck Surg. 2016; Sep. 155(3):514–7.

28. Velasquez N, Thamboo A, Habib AR, Huang Z, Nayak JV. The Empty Nose Syndrome 6-Item Questionnaire (ENS6Q): a validated 6-item questionnaire as a diagnostic aid for empty nose syndrome patients. Int Forum Allergy Rhinol. 2017; Jan. 7(1):64–71.

29. Lee TJ, Fu CH, Wu CL, Lee YC, Huang CC, Chang PH, et al. Surgical outcome for empty nose syndrome: impact of implantation site. Laryngoscope. 2018; Mar. 128(3):554–9.

30. Park MJ, Jang YJ. Successful management of primary atrophic rhinitis by turbinate reconstruction using autologous costal cartilage. Auris Nasus Larynx. 2018; Jun. 45(3):613–6.

31. Borchard NA, Dholakia SS, Yan CH, Zarabanda D, Thamboo A, Nayak JV. Use of intranasal submucosal fillers as a transient implant to alter upper airway aerodynamics: implications for the assessment of empty nose syndrome. Int Forum Allergy Rhinol. 2019; Jun. 9(6):681–7.

32. Thamboo A, Dholakia SS, Borchard NA, Patel VS, Tangbumrungtham N, Velasquez N, et al. Inferior meatus augmentation procedure (IMAP) to treat empty nose syndrome: a pilot study. Otolaryngol Head Neck Surg. 2020; Mar. 162(3):382–5.

33. Chang CF. Using platelet-rich fibrin scaffolds with diced cartilage graft in the treatment of empty nose syndrome. Ear Nose Throat J. 2024; Mar. 103(3):NP168–72.

34. Chang FY, Fu CH, Lee TJ. Outcomes of olfaction in patients with empty nose syndrome after submucosal implantation. Am J Otolaryngol. 2021; Jul-Aug. 42(4):102989.

35. Dholakia SS, Yang A, Kim D, Borchard NA, Chang MT, Khanwalkar A, et al. Long-term outcomes of inferior meatus augmentation procedure to treat empty nose syndrome. Laryngoscope. 2021; Nov. 131(11):E2736–41.

36. Huang CC, Wu PW, Fu CH, Huang CC, Chang PH, Lee TJ. Impact of psychologic burden on surgical outcome in empty nose syndrome. Laryngoscope. 2021; Mar. 131(3):E694–701.

37. Kim DH, Lee MH, Lee J, Song EA, Kim SW, Kim SW. Platelet-rich plasma injection in patients with atrophic rhinitis. ORL J Otorhinolaryngol Relat Spec. 2021; 83(2):104–11.

38. Malik J, Dholakia S, Spector BM, Yang A, Kim D, Borchard NA, et al. Inferior meatus augmentation procedure (IMAP) normalizes nasal airflow patterns in empty nose syndrome patients via computational fluid dynamics (CFD) modeling. Int Forum Allergy Rhinol. 2021; May. 11(5):902–9.

39. Chang MT, Bartho M, Kim D, Tsai EF, Yang A, Dholakia SS, et al. Inferior meatus augmentation procedure (IMAP) for treatment of empty nose syndrome. Laryngoscope. 2022; Jun. 132(6):1285–8.

40. Hosokawa Y, Miyawaki T, Omura K, Akutsu T, Kimura R, Ikezono T, et al. Surgical treatment for empty nose syndrome using autologous dermal fat: evaluation of symptomatic improvement. Ear Nose Throat J. 2022; Sep. 1455613221130885.

41. Huang CC, Wu PW, Lee CC, Huang CC, Fu CH, Chang PH, et al. Comparison of SNOT-25 and ENS6Q in evaluating patients with empty nose syndrome. Laryngoscope Investig Otolaryngol. 2022; Feb. 7(2):342–8.

42. Ushio M, Ishimaru J, Omura S, Ohta Y, Suzuki M. Nasal floor augmentation for empty nose syndrome. Acta Otolaryngol Case Rep. 2022; Dec. 7(1):1–7.

43. Malik J, Thamboo A, Dholakia S, Borchard NA, McGhee S, Li C, et al. The cotton test redistributes nasal airflow in patients with empty nose syndrome. Int Forum Allergy Rhinol. 2020; Apr. 10(4):539–45.

44. Leong SC. The clinical efficacy of surgical interventions for empty nose syndrome: a systematic review. Laryngoscope. 2015; Jul. 125(7):1557–62.

45. Gordiienko IM, Gubar OS, Sulik R, Kunakh T, Zlatskiy I, Zlatska A. Empty nose syndrome pathogenesis and cell-based biotechnology products as a new option for treatment. World J Stem Cells. 2021; Sep. 13(9):1293–306.

46. Wu CL, Fu CH, Lee TJ. Distinct histopathology characteristics in empty nose syndrome. Laryngoscope. 2021; Jan. 131(1):E14–8.

47. el Kholy A, Habib O, Abdel-Monem MH, Abu Safia S. Septal mucoperichondrial flap for closure of nostril in atrophic rhinitis. Rhinology. 1998; Dec. 36(4):202–3.

48. Lobo CJ, Hartley C, Farrington WT. Closure of the nasal vestibule in atrophic rhinitis: a new non-surgical technique. J Laryngol Otol. 1998; Jun. 112(6):543–6.

49. Moon BJ, Lee HJ, Jang YJ. Outcomes following rhinoplasty using autologous costal cartilage. Arch Facial Plast Surg. 2012; May-Jun. 14(3):175–80.

50. Hwang SH, Kim DH, Nam BM, Mun JY, Seong YH, Kim SW. Efficacy and safety of lyophilized articular cartilage matrix as an injectable facial filler. Aesthetic Plast Surg. 2021; Jun. 45(3):1266–72.

51. Moss WJ, Kjos KB, Karnezis TT, Lebovits MJ. Intranasal steroid injections and blindness: our personal experience and a review of the past 60 years. Laryngoscope. 2015; Apr. 125(4):796–800.

52. Kim DH, Kim SW. Clinical applications of human nasal organoids. Clin Exp Otorhinolaryngol. 2022; Aug. 15(3):201–2.

53. Lim MH, Shin S, Park K, Park J, Kim SW, Basurrah MA, et al. Deep learning model for predicting airway organoid differentiation. Tissue Eng Regen Med. 2023; Dec. 20(7):1109–17.

54. Park JH, Park JY, Nam IC, Hwang SH, Kim CS, Jung JW, et al. Human turbinate mesenchymal stromal cell sheets with bellows graft for rapid tracheal epithelial regeneration. Acta Biomater. 2015; Oct. 25:56–64.